2024_08_15

Pinboard

• Type 1 Grand Challenge awards over £2.7 million ($3.5 million) to six research projects on next-generation insulins | Close Concerns #pinboard/ifttt #pinboard/instapaper
• Interview with Dexcom’s CEO Mr. Kevin Sayer discusses the upcoming launch of Stelo, interoperability, and further applications of CGM | Close Concerns #pinboard/ifttt #pinboard/instapaper